AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2PHARMA-January 24, 2012-Novo Nordisk to open Type 1 diabetes R&D centre in Seattle (C)2012 M2 COMMUNICATIONS http://www.m2.com
24 January 2012 - Danish Novo Nordisk A/S (CPH:NOVO B) said on Monday it plans to open a Type 1 diabetes R&D centre in Seattle, Washington.
Mads Krogsgaard Thomsen, Novo Nordisk executive vice president and chief science officer, said that with the new facility, the company hopes to speed up the process of finding new, innovative ways of treating diabetes.
The Novo Nordisk Type 1 Diabetes R&D Center will employ a translational research approach, combining basic research and early …